Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ACRES Commercial Realty C Pref | ACR-C | Nov 25, 2024 | 25.15 | +0.28 |
ACRES Commercial Realty D Pref | ACR-D | Nov 25, 2024 | 22.78 | -0.11 |
Acrivon Therapeutics | ACRV | Nov 25, 2024 | 7.16 | +9.31 |
Actelis Networks | ASNS | Nov 25, 2024 | 1.28 | +5.79 |
Actinium Pharmaceuticals | ATNM | Nov 25, 2024 | 1.45 | 0.00 |
Active Bear ETF | HDGE | Nov 25, 2024 | 16.74 | -1.79 |
Active U.S. Real Estate Powershares | PSR | Nov 25, 2024 | 98.53 | +1.22 |
Actuate Therapeutics | ACTU | Nov 25, 2024 | 9.15 | +1.89 |
Acuity Brands | AYI | Nov 25, 2024 | 329.79 | +1.09 |
Acumen Pharmaceuticals | ABOS | Nov 25, 2024 | 2.36 | -0.42 |
Acurx Pharmaceuticals | ACXP | Nov 25, 2024 | 1.32 | -2.22 |
Acushnet | GOLF | Nov 25, 2024 | 74.21 | +3.13 |
ACV Auctions A | ACVA | Nov 25, 2024 | 22.96 | +4.51 |
ACWI Ex-US Index MSCI Ishares | ACWX | Nov 25, 2024 | 53.96 | +0.28 |
ACWI Index MSCI Ishares | ACWI | Nov 25, 2024 | 120.86 | +0.35 |
Adagene ADR | ADAG | Nov 25, 2024 | 2.27 | +3.49 |
Adagio Medical | ADGM | Nov 25, 2024 | 2.60 | +5.26 |
Adams Diversified Equity Fund | ADX | Nov 25, 2024 | 20.44 | +0.10 |
Adams Natural Resources Fund | PEO | Nov 25, 2024 | 23.82 | -0.29 |
Adams Resources & Energy | AE | Nov 25, 2024 | 37.40 | +0.54 |
AdaptHealth | AHCO | Nov 25, 2024 | 10.12 | +2.69 |
Adaptimmune Therapeutics ADR | ADAP | Nov 25, 2024 | 0.70 | +5.37 |
Adaptive Biotechnologies | ADPT | Nov 25, 2024 | 5.58 | +18.98 |
ADC Therapeutics SA | ADCT | Nov 25, 2024 | 2.03 | +2.01 |
Addentax Group | ATXG | Nov 25, 2024 | 0.56 | +1.14 |
Addex Therapeutics ADR | ADXN | Nov 25, 2024 | 7.95 | +5.58 |
Addus HomeCare | ADUS | Nov 25, 2024 | 122.95 | -1.10 |
Adecoagro | AGRO | Nov 25, 2024 | 11.04 | -0.72 |
Adeia | ADEA | Nov 25, 2024 | 12.25 | +1.66 |
Adial Pharmaceuticals | ADIL | Nov 25, 2024 | 1.01 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.